Back
Markel Group Vs. Akero Therapeutics Industry Stock Comparison
Buy
56
MKL
Markel Group
Last Price:
$1,826.98
Seasonality Move:
8%
Buy
59
AKRO
Akero Therapeutics
Last Price:
$54.05
Seasonality Move:
-13.54%
Buy
56
Markel Group (MKL)
is a Buy
Is Markel Group a Buy, Sell or Hold?
-
The current Markel Group [MKL] share price is $1,828.78. The Score for MKL is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
MKL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $54.08. The Score for AKRO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MKL Stock Price Chart
What is Markel Group's stock price today?
-
The Markel Group share price today is $1,828.78Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MKL is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $54.08Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.
MKL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 29.42 | Buy |
Relative Strength Index (14 RSI): | 65.79 | Buy |
Chaikin Money Flow: | 2142 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1705.98 - 1808.3) | Buy |
Bollinger Bands (100): | (1570.01 - 1757.37) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.25 | Buy |
Relative Strength Index (14 RSI): | 82.91 | Buy |
Chaikin Money Flow: | -280479 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.47 - 42.61) | Buy |
Bollinger Bands (100): | (24.31 - 36.07) | Buy |
MKL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1819.21 | Buy |
20-day SMA: | 1761.47 | Buy |
50-day SMA: | 1747.38 | Buy |
200-day SMA: | 1614.82 | Buy |
8-day EMA: | 1812.07 | Buy |
20-day EMA: | 1780.48 | Buy |
50-day EMA: | 1737.18 | Buy |
200-day EMA: | 1625.68 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43 | Buy |
20-day SMA: | 32.36 | Buy |
50-day SMA: | 31 | Buy |
200-day SMA: | 26.7 | Buy |
8-day EMA: | 45.65 | Buy |
20-day EMA: | 36.88 | Buy |
50-day EMA: | 32.36 | Buy |
200-day EMA: | 28.76 | Buy |
Markel Group Earnings Growth & MKL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.94 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.62 per share, and an increase next year of $13.58 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.10 per share.
Markel Group Technical Analysis
Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Jan 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Jan 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |